DEFAZIO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 8.159
EU - Europa 1.222
AS - Asia 545
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 9.929
Nazione #
US - Stati Uniti d'America 8.145
CN - Cina 477
UA - Ucraina 280
SE - Svezia 254
DE - Germania 199
IT - Italia 168
FI - Finlandia 166
GB - Regno Unito 74
BE - Belgio 28
SG - Singapore 27
IE - Irlanda 16
IR - Iran 16
IN - India 14
CA - Canada 13
FR - Francia 11
CZ - Repubblica Ceca 10
RU - Federazione Russa 9
KR - Corea 5
BD - Bangladesh 3
VN - Vietnam 2
AU - Australia 1
BG - Bulgaria 1
CO - Colombia 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
ME - Montenegro 1
MX - Messico 1
NL - Olanda 1
PL - Polonia 1
RO - Romania 1
TR - Turchia 1
Totale 9.929
Città #
Fairfield 1.316
Woodbridge 1.024
Houston 649
Jacksonville 634
Chandler 623
Ashburn 537
Seattle 527
Cambridge 431
Ann Arbor 411
Wilmington 385
Lawrence 162
Nanjing 162
Roxbury 162
Nyköping 145
Des Moines 105
New York 98
Princeton 85
Boardman 73
Beijing 68
San Diego 54
Nanchang 44
Shenyang 44
Inglewood 41
Hebei 38
Jiaxing 29
Brussels 28
Bari 20
San Mateo 17
Changsha 16
Dublin 16
Norwalk 16
Singapore 15
Tianjin 14
London 12
Los Angeles 12
Augusta 11
Brooklyn 11
Leawood 11
Milan 11
Brno 10
Ardabil 9
Dearborn 9
Guangzhou 9
Rome 9
Monmouth Junction 8
Pune 8
Helsinki 7
Palermo 6
Toronto 6
Auburn Hills 5
Falls Church 5
Padova 5
Turin 5
Washington 5
Kunming 4
Marseille 4
Ningbo 4
Paris 4
Zhengzhou 4
Bologna 3
Cassano delle Murge 3
Formia 3
Mumbai 3
Naples 3
Prescot 3
Sabz 3
St Petersburg 3
Wuhan 3
Accettura 2
Acton 2
Amantea 2
Brescia 2
Capannori 2
Carpi 2
Dong Ket 2
Edinburgh 2
Frankfurt am Main 2
Genoa 2
Grafing 2
Indiana 2
Jinan 2
Jinhua 2
Kish 2
Kyiv 2
Montréal 2
Munich 2
Ostuni 2
Paderno Dugnano 2
Palosco 2
Redmond 2
Redwood City 2
Shanghai 2
Taizhou 2
Taranto 2
Acquaviva Delle Fonti 1
Albugnano 1
Amsterdam 1
Ascoli Piceno 1
Athens 1
Athol 1
Totale 8.268
Nome #
Bilateral striatal necrosis, dystonia and multiple mitochondrial DNA deletions: case study and effect of deep brain stimulation 123
IMMUNOPATOLOGIA DELLA SCLEROSI MULTIPLA 112
Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings 108
Genome-wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus? 106
Action tremor in Parkinson's disease: frequency and relationship to motor and non-motor signs 105
No association between essential tremor and migraine: A case-control study 102
A comparative study of primary and secondary hemifacial spasm 98
Relationship between eye symptoms and blepharospasm: a multicenter case-control study 96
Onset and spread of dyskinesias and motor symptoms in Parkinson's disease 93
Frequency of familial aggregation in primary adult-onset cranial cervical dystonia 93
Brain F-18 Fluorocholine PET/CT for the Assessment of Optic Pathway Glioma in Neurofibromatosis-1 92
Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. 91
Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatment 90
Antineuronal antibody status and phenotype analysis in Tourette's syndrome 90
Camptocormia in Parkinson disease: an epidemiological and clinical study 90
L-Dopa Related Hyperhomocysteinemia: A Possible Mediator of Toxicity?. 88
null 88
Are nongenetic triggers for dystonia type-specific? A study exploring scoliosis in blepharospasm 87
The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort 87
Headache in cranial and cervical dystonia 87
Assessment of voice and speech symptoms in early Parkinson’s disease by the Robertson dysarthria profile 87
Agreement among neurologists on the clinical diagnosis of dystonia at different body sites 86
Anti-basal ganglia antibodies and Tourette's syndrome: a voxel-based morphometry and diffusion tensor imaging study in an adult population 86
Antineuronal antibodies in cranial dystonia. 85
The phenomenology of the geste antagoniste in primary blepharospasm and cervical dystonia 84
Development and validation of a clinical guideline for diagnosing blepharospasm 84
The natural history of treated PD in an incident, community-based cohort: does the future begin? 84
Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders 83
Post-streptococcal 'complex' movement disorders: unusual concurrence of psychogenic and organic symptoms 83
Hyperalgesia and laser evoked potentials alterations in hemiparkinson: evidence for an abnormal nociceptive processing 82
La tossina botulinica nel recupero del piede equino-valgo da paralisi cerebrale infantile 81
Cortical gray matter changes in primary blepharospasm: a voxel-based morphometry study 80
EPIDEMIOLOGY OF PRIMARY BLEPHAROSPASM 78
Spontaneous pain, pain threshold, and pain tolerance in Parkinson's disease 78
Personality disorders and somatization in functional and organic movement disorders 77
Defective temporal processing of sensory stimuli in DYT1 mutation carriers: a new endophenotype of dystonia? 77
Manganese toxicity in serumless dissociated mesencephalic and striatal primary culture 76
Epidemiology of primary and secondary dystonia 76
Pain and motor complications in Parkinson's disease 75
Abnormal tactile temporal discrimination in psychogenic dystonia 75
Psychiatric disorders in patients with essential tremor 75
Sleep and cranial dystonia 74
Endocytosis of horseradish peroxidase by brain microvascular and umbilical vein endothelial cells in culture: an ultrastructural and morphometric study 74
Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia 72
A family study on primary blepharospasm 72
Quality of sleep in primary focal dystonia: a case-control study 72
Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia 72
Disease modeling in functional movement disorders 71
Abnormal processing of the nociceptive input in Parkinson's disease: a study with CO2 laser evoked potentials 71
Temporal discrimination in patients with dystonia and tremor and patients with essential tremor 70
Diffusion tensor imaging in patients with primary cervical dystonia and in patients with blepharospasm 70
null 70
Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias 70
The epidemiology of primary dystonia: current evidence and perspectives 70
Ataxia in posterior circulation stroke: clinical-MRI correlations 70
Mirror movements in patients with Parkinson's disease 70
Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1a 70
Time processing in children with Tourette's syndrome 69
Is increased blinking a form of blepharospasm? 69
Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials 69
Botulinum A toxin for the so-called apraxia of lid opening 69
Epidemiology of primary dystonia 68
ANTINFLAMMATORY EFFECTS OF RIFNB-1B IN MULTIPLE SCLEROSIS: LONGITUDINAL CHANGES OF THE SERUM SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 (SICAM-1), TNFA AND T-CELL SUBSETS 68
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia 68
How pain arises in Parkinson's disease 68
Epidemiology of primary and secondary dystonia 67
Epidemiology of primary blepharospasm 67
Defining the epsilon-sarcoglycan (SGCE) gene phenotypic signature in myoclonus-dystonia: a reappraisal of genetic testing criteria . 67
Familial blepharospasm is inherited as an autosomal dominant trait and relates to a novel unassigned gene 67
Analisi longitudinale dei livelli sierici di ICAM-1 solubile e dei subsets di linfociti T in pazienti con Sclerosi Multipla a decorso remittente in trattamento con IFNb-1b 67
Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group 67
Midbrain SERT in degenerative parkinsonisms: A 123I-FP-CIT SPECT study 67
Eye symptoms in relatives of patients with primary adult-onset dystonia 66
Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24) 66
The epidemiology of pain in Parkinson's disease 65
Long-term assessment of the risk of spread in primary late-onset focal dystonia 65
Do primary adult-onset focal dystonias share aetiological factors? 65
Phenotypic overlap in familial and sporadic primary adult-onset extracranial dystonia 65
Soluble adhesion molecules in Gilles de la Tourette's syndrome 65
Botulinum A toxin treatment for eyelid spasm, spasmodic torticollis and apraxia of eyelid opening 65
The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder 65
Brain-derived neurotrophic factor and risk for primary adult-onset cranial-cervical dystonia 65
Dopaminomimetic action of diphenylhydantoin in rat striatum: effect on homovanillic acid and cyclic AMP levels 64
Tracing Sydenham's chorea: historical documents from a British paediatric hospital 63
null 63
Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials 62
Influence of age on the association between primary hemifacial spasm and arterial hypertension 62
The influence of electroencephalographic focus laterality on efficacy of carbamazepine in complex partial and secondarily generalized tonic-clonic seizures 62
Parkinsonian serum carries complement-dependent toxicity for rat mesencephalic dopaminergic neurons in culture 62
Primary Cervical dystonia and scoliosis: a multicenter case-control study 62
Sensitivity and specificity of a self-administered questionnaire for familial screening of adult-onset dystonia 61
Primary hemifacial spasm and arterial hypertension: a multicenter case-control study 61
Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions 61
Fatigue in Parkinson's disease 61
"Apraxia of eyelid opening" induced by levodopa therapy and apomorphine in atypical parkinsonism (possible progressive supranuclear palsy): a case report 60
Pathophysiology of somatosensory abnormalities in Parkinson disease. 60
null 60
Sensitivity and specificity of a self-administered questionnaire for familial screening of adult-onset dystonia 59
CHANGES OF SERUM ICAM-1 AND MMP-9 INDUCED BY RIFNB-1B TREATMENT IN RELAPSING-REMITTING MS 59
Impaired cognitive functions in adult-onset primary cranial cervical dystonia 58
Totale 7.525
Categoria #
all - tutte 35.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.123


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.021 540 206 109 319 344 189 298 259 362 114 211 70
2020/20211.554 155 109 169 81 141 77 127 106 150 203 153 83
2021/2022930 45 66 5 33 56 96 29 46 103 89 158 204
2022/20231.478 267 118 45 168 219 202 7 147 234 5 36 30
2023/2024624 51 112 27 118 34 139 4 18 2 11 29 79
2024/202521 21 0 0 0 0 0 0 0 0 0 0 0
Totale 10.019